BRINGING EVIDENCE CLOSER TO HEALTHCARE DECISIONS
We generate instruments for decision making in access and pharmacoeconomics through the use of scientific evidence and analysis.
We influence decision making in health policies through the development of reliable, honest and effective instruments.
We carry out processes of inclusion to the National Formulary of Medicines and Supplies and to institutional formularies fulfilling and exceeding the requirements of each of the public institutions.
Access services offered by TIS
- Dossier preparation for inclusion in the National Formulary and in the different public or private formulary lists
- Development of a specific value proposal for each product, highlighting the appropriate language and added values
- Design of Access Plans
- Mapping of opinion leaders, decision makers and payers (KOLs)
- Mapping of patient flow
- Market valuation and probabilities of achievieng access for a product
- Economic evaluations to support access to markets
- Research of national and international best practices
Map of actors for an access process
Any strategy of inclusion of health technologies (medicine, consumable or medical device) requires promotional work. This activity can be analyzed in two components: contact activities and communication activities.
In the context of the country’s health sector, there are six main institutions that provide or fund health services in the public sector (IMSS, ISSSTE, PEMEX, SEDENA, SEMAR and SEGURO POPULAR) and a diverse range of providers in the private sector. To effectively access these institutions and markets, it is a necessary condition to map the relevant actors in an inclusion process.
In each map it is possible to distinguish three levels of actors:
a) Decision makers and their formal influencers
b) Informal advisors and influencers
c) “Shadow” experts or influencers outside the institution
These types of maps support the planning of an access strategy as they allow one to identify the weight of the actors in each institution, their direct influencers and those “shadow” actors or institutions that intervene in access decisions.
The maps can also incorporate the main processes of analysis of inclusion requests depending on the clinical characteristics of each pathology and, above all, the budget impact that all inclusion have on the health system.
This product will allow your access strategy to be based on the most efficient contact and communication activities.
- Support the client in understanding the main actors in an access process.
- Identify the formal and informal communication channels within the institutions of interest.
- Explain the technical requirements of the access process.
- Distinguish non-visible opportunities that can positively influence an inclusion strategy.
This work is divided into two stages. The first consists of desk research and interviews with experts within the institutions of interest, with an estimated duration of three weeks. The second in the presentation and iteration process of the maps with the client, with a duration of two weeks.
At the end of these exercises, TIS is available to collaborate in the design of an access strategy and, where appropriate, conduct the economic evaluation and report of the referred technology. It is also possible to follow up the access strategy by training the sales force and medical teams in value messages from an economic perspective.